45 studies found for:    " December 29, 2010":" January 28, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
Conditions: HIV Infection;   Hepatitis C Infection;   Fibrosis;   Inflammation
Intervention:
22 Withdrawn Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.
Conditions: HIV Infections;   Healthy
Interventions: Drug: BI 224436;   Drug: Placebo
23 Active, not recruiting Study of Options for Second-Line Effective Combination Therapy (SELECT)
Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Abacavir/lamivudine/zidovudine;   Drug: Abacavir/lamivudine;   Drug: Lamivudine/zidovudine;   Drug: Abacavir;   Drug: Zidovudine;   Drug: Lamivudine
24 Withdrawn A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: 200mg [14C]- GSK2248761
25 Unknown  Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients
Condition: HIV
Intervention: Drug: Etoricoxib
26 Completed
Has Results
Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia
Condition: HIV
Intervention: Drug: HIV therapy
27 Completed Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
Conditions: HIV;   Sexually Transmitted Diseases
Intervention: Behavioral: It's Your Game Tech
28 Active, not recruiting Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
Condition: HIV
Intervention: Drug: MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
29 Completed Electronic Intervention for HIV Medication Adherence
Condition: HIV
Intervention: Behavioral: Life Steps for Medication Adherence
30 Completed
Has Results
Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination
Conditions: HIV;   Rabies
Intervention: Biological: rabies vaccines on day 0 and 3
31 Not yet recruiting Project Wellness: Increasing HIV Testing Among West African Immigrants
Conditions: Diabetes;   Hypertension;   HIV
Interventions: Behavioral: HIV testing;   Behavioral: General Health Screen
32 Completed Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
33 Completed Rwanda Selenium Supplementation Clinical Trial
Condition: HIV
Interventions: Dietary Supplement: Selenium;   Other: Placebo
34 Active, not recruiting Microbicide Safety and Acceptability in Young Men
Conditions: High Risk MSM;   HIV Negative;   18-30 Years of Age
Interventions: Other: HEC Placebo Gel;   Drug: Tenofovir 1% Gel
35 Completed Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers
Condition: HIV
Intervention: Drug: Emtricitabine/tenofovir
36 Completed
Has Results
Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
Condition: HIV
Interventions: Drug: Tenofovir/emtricitabine;   Drug: Tenofovir/emtricitabine/efavirenz;   Drug: Raltegravir
37 Recruiting High Risk Crack Use Settings and HIV in El Salvador
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: Social Network HIV Testing;   Behavioral: Peer Network Intervention
38 Active, not recruiting Safer Sex Intervention for Male Clients of Female Sex Workers in Tijuana, Mexico
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: Hombre Seguro;   Behavioral: Didactic attention-control condition
39 Completed A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers
Condition: HIV
Interventions: Drug: TMC278;   Drug: Efavirenz
40 Recruiting Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle
Condition: HIV
Interventions: Behavioral: FAmily CEntered (FACE) ACP;   Behavioral: Healthy Living Control

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results
Indicates status has not been verified in more than two years